Showing results (211-220 of 405) with videos related to

Sort By:
Pageof 41
Neurologic Clinics|March 29, 2011
Pediatric multiple sclerosisTanuja Chitnis, Lauren Krupp, Ann Yeh, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
Effect of vitamin D on MS activity by disease-modifying therapy classDalia L Rotstein, Brian C Healy, Muhammad T Malik, et al.
BMC Neurology|November 13, 2013
Increased leptin and A-FABP levels in relapsing and progressive forms of MSSilvia Messina, David Vargas-Lowy, Alexander Musallam, et al.
Multiple Sclerosis and Related Disorders|November 17, 2017
Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosisTessa Eagle, Fiona Stuart, Alicia S Chua, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 6, 2013
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker developmentPia Kivisäkk, Brian C Healy, Katiana Francois, et al.
Neurology|September 6, 2015
The 2D:4D ratio, a proxy for prenatal androgen levels, differs in men with and without MSRiley Bove, Muhammed T Malik, Camilo Diaz-Cruz, et al.
Neuroimage. Clinical|July 23, 2015
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect modelsAlicia S Chua, Svetlana Egorova, Mark C Anderson, et al.
Multiple Sclerosis and Related Disorders|October 8, 2021
Current international trends in the treatment of multiple sclerosis in children-Impact of the COVID-19 pandemicFredrik Sandesjö, Evangeline Wassmer, Kumaran Deiva, et al.
The Journal of Experimental Medicine|July 9, 2003
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitisAlan D Salama, Tanuja Chitnis, Jaime Imitola, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patientsChristian Barro, Brian C Healy, Shrishti Saxena, et al.
Pageof 41